Annual Non Current Assets
$2.57 M
-$66.00 K-2.50%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual long term assets is $2.57 million, with the most recent change of -$66.00 thousand (-2.50%) on December 31, 2023.
- During the last 3 years, RGLS annual non current assets has risen by +$1.70 million (+194.16%).
- RGLS annual non current assets is now -80.50% below its all-time high of $13.19 million, reached on December 31, 2016.
Performance
RGLS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$2.08 M
-$1.71 M-45.09%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly long term assets is $2.08 million, with the most recent change of -$1.71 million (-45.09%) on September 30, 2024.
- Over the past year, RGLS quarterly non current assets has dropped by -$1.71 million (-45.09%).
- RGLS quarterly non current assets is now -84.84% below its all-time high of $13.69 million, reached on June 30, 2016.
Performance
RGLS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RGLS Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | -45.1% |
| 3 y3 years | +194.2% | -28.5% |
| 5 y5 years | -70.2% | +10.4% |
RGLS Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | at low | -83.6% | at low |
| 5 y | 5-year | -20.1% | +194.2% | -83.6% | +137.5% |
| alltime | all time | -80.5% | +194.2% | -84.8% | +137.5% |
Regulus Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.08 M(-45.1%) |
| Jun 2024 | - | $3.78 M(-70.2%) |
| Mar 2024 | - | $12.69 M(+393.6%) |
| Dec 2023 | $28.18 M(-36.1%) | $2.57 M(-3.5%) |
| Sep 2023 | - | $2.67 M(+16.7%) |
| Jun 2023 | - | $2.28 M(-6.9%) |
| Mar 2023 | - | $2.45 M(-7.0%) |
| Dec 2022 | $44.08 M(-32.4%) | $2.64 M(-4.2%) |
| Sep 2022 | - | $2.75 M(-5.1%) |
| Jun 2022 | - | $2.90 M(-4.9%) |
| Mar 2022 | - | $3.05 M(-5.2%) |
| Dec 2021 | $65.23 M(+77.6%) | $3.22 M(+5.3%) |
| Sep 2021 | - | $3.06 M(-4.6%) |
| Jun 2021 | - | $3.20 M(-3.1%) |
| Mar 2021 | - | $3.30 M(+278.0%) |
| Dec 2020 | $36.73 M(-9.1%) | $874.00 K(-15.6%) |
| Sep 2020 | - | $1.04 M(-13.2%) |
| Jun 2020 | - | $1.19 M(-14.7%) |
| Mar 2020 | - | $1.40 M(-16.4%) |
| Dec 2019 | $40.41 M(+109.4%) | $1.67 M(-11.0%) |
| Sep 2019 | - | $1.88 M(+33.7%) |
| Jun 2019 | - | $1.41 M(-34.2%) |
| Mar 2019 | - | $2.14 M(-75.2%) |
| Dec 2018 | $19.30 M | $8.63 M(-7.5%) |
| Sep 2018 | - | $9.33 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $9.94 M(-6.7%) |
| Mar 2018 | - | $10.65 M(-3.8%) |
| Dec 2017 | $66.74 M(-23.7%) | $11.07 M(-1.8%) |
| Sep 2017 | - | $11.28 M(-5.3%) |
| Jun 2017 | - | $11.92 M(-4.9%) |
| Mar 2017 | - | $12.53 M(-5.0%) |
| Dec 2016 | $87.47 M(-34.8%) | $13.19 M(-1.9%) |
| Sep 2016 | - | $13.44 M(-1.9%) |
| Jun 2016 | - | $13.69 M(+10.6%) |
| Mar 2016 | - | $12.38 M(+81.4%) |
| Dec 2015 | $134.26 M(-18.6%) | $6.83 M(+2.8%) |
| Sep 2015 | - | $6.64 M(+7.5%) |
| Jun 2015 | - | $6.18 M(-2.4%) |
| Mar 2015 | - | $6.33 M(-3.0%) |
| Dec 2014 | $164.95 M(+40.8%) | $6.53 M(+9.0%) |
| Sep 2014 | - | $5.99 M(-0.7%) |
| Jun 2014 | - | $6.04 M(+2.7%) |
| Mar 2014 | - | $5.88 M(-0.1%) |
| Dec 2013 | $117.18 M(+18.5%) | $5.88 M(+10.9%) |
| Sep 2013 | - | $5.30 M(-6.0%) |
| Jun 2013 | - | $5.64 M(+7.3%) |
| Mar 2013 | - | $5.26 M(+14.6%) |
| Dec 2012 | $98.93 M(+155.9%) | $4.59 M(-27.9%) |
| Sep 2012 | - | $6.36 M(+13.9%) |
| Jun 2012 | - | $5.59 M(+32.5%) |
| Dec 2011 | $38.67 M | $4.21 M |
FAQ
- What is Regulus Therapeutics annual long term assets?
- What is the all time high annual non current assets for Regulus Therapeutics?
- What is Regulus Therapeutics annual non current assets year-on-year change?
- What is Regulus Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly non current assets year-on-year change?
What is Regulus Therapeutics annual long term assets?
The current annual non current assets of RGLS is $2.57 M
What is the all time high annual non current assets for Regulus Therapeutics?
Regulus Therapeutics all-time high annual long term assets is $13.19 M
What is Regulus Therapeutics annual non current assets year-on-year change?
Over the past year, RGLS annual long term assets has changed by -$66.00 K (-2.50%)
What is Regulus Therapeutics quarterly long term assets?
The current quarterly non current assets of RGLS is $2.08 M
What is the all time high quarterly non current assets for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly long term assets is $13.69 M
What is Regulus Therapeutics quarterly non current assets year-on-year change?
Over the past year, RGLS quarterly long term assets has changed by -$1.71 M (-45.09%)